Dr Reddys Laboratories Share Price Today - Live Blog for June 17, 2025

Dr Reddys Laboratories Ltd witnessed a -0.16% decrease in its share price, and it is currently trading at ₹1,318.40. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.8700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.16% drop, and it's now trading at ₹1,318.35 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.19%, reaching the current market price of ₹1,318.75. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a remarkable 0.85% surge in its share price and is presently trading at ₹1,317.70. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd observed a -2.04% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,308.75. The stock has a PE ratio of 19.8700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd stock price decreased by -0.01%, with the current market value at ₹1,336.55 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Dr Reddys Laboratories Ltd is facing a -0.03% decline and is currently trading at ₹1,336.65 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.05% in its share price, and it currently trades at ₹1,337.30 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.13%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,338.00 per share.

Dr Reddys Laboratories Ltd witnessed a -0.03% drop in its share price and is currently trading at ₹1,336.45. With the stock's PE at 19.8700 and the industry PE at 34.8804, investors are weighing their options.

With a -0.03% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,336.80. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.8700, while the industry PE is 34.8804.

Dr Reddys Laboratories Ltd share price has declined by -0.09%, and it's currently trading at ₹1,338.10. The stock maintains a PE of 19.8700, while the industry PE is 34.8804, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd experienced a -0.09% downturn in its share price, and it's currently trading at ₹1,338.10. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd's stock price surged by 0.03%, reaching the current market value of ₹1,339.25 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd's stock has surged by 0.04%, and it is currently trading at ₹1,338.90. Additionally, the stock maintains a PE ratio of 19.8700, while the industry PE is 34.8804.

Dr Reddys Laboratories Ltd experienced a -0.09% downturn in its share price, and it's currently trading at ₹1,336.85. This situation is generating interest among value investors who are evaluating the stock's potential.

Following a noteworthy 0.21% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,338.00. When it comes to valuation, this stock has a PE ratio of 19.8700, with the industry PE ratio at 34.8804.

Dr Reddys Laboratories Ltd shares saw a -0.17% decrease, reaching a current market price of ₹1,338.70. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.8700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a -0.13% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,341.90. The stock has a PE ratio of 19.8700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd experienced a -0.13% slump and is currently trading at ₹1,341.90. While the stock maintains a PE ratio of 19.8700, the industry PE is 34.8804, raising questions about valuation.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.26% in its share price, and it currently trades at ₹1,334.90 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.26% drop, and it's now trading at ₹1,334.90 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.03% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,338.40 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a -0.28% decrease, reaching a current market price of ₹1,340.00. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.8700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.45%, reaching the current market price of ₹1,342.80. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a -0.24% decrease, reaching a current market price of ₹1,336.80. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.8700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.